JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Application Note
Biochemical binding ADCC assays utilizing LANCE toolbox reagents for the characterization of hIgGs and FcγR1A
This application note presents a biochemical binding assay based on LANCE™ TR-FRET technology to characterize interactions between human IgGs and FcγRI (CD64). The approach provides accurate measurement of antibody binding affinity to support therapeutic antibody research and mechanism-of-action studies.
Key highlights:
- High-throughput TR-FRET assay for quantifying FcγRI–IgG interactions and calculating IC₅₀ values for antibody binding affinity
- Flexible assay configuration compatible with multiple Fc receptors and scalable across 384-well and 96-well formats.
- Supports biologics workflows from early discovery to GMP lot release with robust and transferable performance.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Biochemical binding ADCC assays utilizing LANCE toolbox reagents for the characterization of hIgGs and FcγR1A